tiprankstipranks
Trending News
More News >
Pharmaron Beijing Co., Ltd. Class H (DE:17Q1)
FRANKFURT:17Q1
Germany Market

Pharmaron Beijing Co., Ltd. Class H (17Q1) Income Statement

Compare
0 Followers

Pharmaron Beijing Co., Ltd. Class H Income Statement

Last quarter (Q1 2025), Pharmaron Beijing Co., Ltd. Class H's total revenue was ¥3.10B, an increase of 16.03% from the same quarter last year. In Q1, Pharmaron Beijing Co., Ltd. Class H's net income was ¥305.58M. See Pharmaron Beijing Co., Ltd. Class H’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 24Dec 23Dec 22Dec 21Dec 20
Total Revenue
¥ 12.28B¥ 11.54B¥ 10.27B¥ 7.44B¥ 5.13B
Gross Profit
¥ 4.20B¥ 4.12B¥ 3.77B¥ 2.68B¥ 1.92B
Operating Expenses
¥ 2.10B¥ 2.28B¥ 2.02B¥ 1.15B¥ 838.94M
Depreciation and Amortization
¥ 1.05B¥ 927.17M¥ 696.18M¥ 497.92M¥ 375.16M
EBITDA
¥ 3.38B¥ 2.95B¥ 2.53B¥ 2.49B¥ 1.72B
Operating Income
¥ 2.10B¥ 1.85B¥ 1.69B¥ 1.91B¥ 1.32B
Other Income/Expenses
¥ -13.20M¥ -10.01M¥ -23.50M¥ -3.34M¥ -4.47M
Pretax Income
¥ 2.09B¥ 1.84B¥ 1.67B¥ 1.91B¥ 1.32B
Net Income
¥ 1.79B¥ 1.60B¥ 1.37B¥ 1.66B¥ 1.17B
Per Share Metrics
Basic EPS
¥ 1.00¥ 1.00¥ 1.16¥ 1.40¥ 0.99
Diluted EPS
¥ 1.00¥ 1.00¥ 1.16¥ 1.37¥ 0.99
Weighted Average Shares Outstanding
1.79B 1.77B 1.18B 1.21B 1.19B
Weighted Average Shares Outstanding (Diluted)
1.79B 1.78B 1.18B 1.21B 1.19B
Currency in CNY

Pharmaron Beijing Co., Ltd. Class H Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis